News and Press Releases
Media Contact: Jenn Beeson, [email protected]
Enable Injections Announces Agreement with Sobi to Develop and Distribute Aspaveli in Combination with enFuse in Sobi Territories
September 12, 2024 – Globe Newswire
Enable Injections Names Matthew Huddleston as Chief Commercial Officer
May 22, 2024 – Globe Newswire
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse for Advanced Parkinson’s Disease
May 15, 2024 – Globe Newswire
Fierce Medtech Names Enable Injections a “Fierce 15” Company of 2023
March 5, 2024 – PR Newswire
Enable Injections Announces Plans to Expand Manufacturing Facilities and Corporate Headquarters
February 14, 2024 – PR Newswire
Enable Injections Appoints David Kroekel as Chief Operating Officer
February 7, 2024 – PR Newswire
Enable Injections Enhances Board with Addition of Vickie Capps
November 7, 2023 – PR Newswire